NOVARTIS AG holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 1,258,639 | $140,313,085 | 4.24% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 23, 2025 |
| June 30, 2025 | 1,262,444 | $152,769,793 | 4.40% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 14, 2025 |
| Sept. 30, 2025 | 1,210,948 | $155,293,439 | 3.90% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 13, 2025 |
| Dec. 31, 2025 | 962,900 | $132,756,440 | 3.57% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Jan. 15, 2026 |
| March 31, 2026 | 589,232 | $90,007,019 | 2.77% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 13, 2026 |
| June 30, 2026 | 310,818 | $48,713,005 | 1.61% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 13, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.